1-866-735-2792
Talk to a personal injury lawyer.
Heparin Internet Resources
Baxter's Multiple-dose Vial Heparin Linked to Severe Allergic Reactions
The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high bolus doses of the drug.
Baxter Healthcare Issues Urgent Nationwide Heparin Multi-Dose Vial Recall
Baxter Healthcare Corporation has announced the voluntary recall of nine lots of heparin sodium injection 1000 units/mL 10mL and 30mL multi-dose vials. The company began recalling the lots on January 17, 2008 as a precautionary measure due to an increase in the number of reports of adverse patient reactions that may be associated with the product.
Contact Our Heparin Recall Lawyers Today »
National Kidney & Urologic Disease Information Clearinghouse
This site has everything from A to Z regarding kidneys and kidney health with a large section explaining dialysis, specifically hemodialysis and how it relates to the blood.
